- Report
- April 2022
- 40 Pages
Ireland
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2022
- 40 Pages
Japan
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2022
- 40 Pages
Russia
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2022
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2022
- 40 Pages
South Korea
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2022
- 40 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2022
- 40 Pages
Vietnam
From €1481EUR$1,500USD£1,233GBP
- Report
- February 2022
- 100 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- November 2021
- 40 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2021
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- August 2021
- 40 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2020
- 100 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- October 2024
- 25 Pages
Taiwan
From €995EUR$1,079USD£857GBP
- Report
- October 2024
- 24 Pages
Saudi Arabia
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 26 Pages
Australia
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 27 Pages
Canada
From €995EUR$1,079USD£857GBP
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 28 Pages
United Kingdom
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 23 Pages
China
From €995EUR$1,079USD£857GBP
- Report
- September 2024
- 25 Pages
Italy
From €995EUR$1,079USD£857GBP
The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more